tradingkey.logo
tradingkey.logo
Search

Axsome's depression treatment fails to meet main goal of late-stage study

ReutersApr 1, 2025 11:10 AM
facebooktwitterlinkedin

- Axsome Therapeutics AXSM.O said on Tuesday its experimental drug to treat major depressive disorder failed to meet the main goal of a late-stage study.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI